Three-drug Chemotherapy Combination Increases Organ Preservation In Patients With Larynx Cancer
Wednesday, April 1, 2009 - 13:28
in Health & Medicine
Patients with larynx cancer who received a three-drug combination of docetaxel, cisplatin and 5-fluorouracil during induction chemotherapy were more likely to retain larynx function than were patients treated with cisplatin and 5-fluoruracil alone, according to data from a randomized controlled trial.